High-Yield Infectious Disease for USMLE Step 3: Sepsis, HIV, and Antibiotics

Most candidates walk into Step 3 thinking infectious disease is about memorizing bug-drug pairs. It isn't. ID is the single broadest testing domain on the exam, and the questions that trip people up aren't pharmacology recall — they're clinical decision-making under uncertainty. Should you start antibiotics before the cultures come back? Obviously yes in sepsis, but the exam will punish you for forgetting blood cultures first. Can you give a live vaccine to your transplant patient's household contact? (Yes, actually — with one exception I'll get to below.)

I've watched residents lose easy points on ID questions they "knew" because they applied the right knowledge in the wrong sequence. Let's fix that.

Sepsis and Septic Shock

Definitions (Sepsis-3)

• Sepsis: life-threatening organ dysfunction (SOFA score increase ≥ 2) caused by a dysregulated host response to infection
• Septic shock: sepsis + vasopressor requirement + lactate > 2 mmol/L despite adequate fluid resuscitation

The older SIRS-based definitions still show up in answer explanations, but the exam has fully adopted Sepsis-3. Don't waste time calculating SIRS criteria when the question is clearly testing SOFA-based recognition.

The Hour-1 Bundle

This gets tested in both MCQ and CCS format, and the order matters more than most people realize. Here's the sequence — burn it in:

1. Measure lactate — repeat if > 2 (you're tracking clearance, not just getting a number)
2. Blood cultures (2 sets from 2 different sites) before antibiotics
3. Broad-spectrum antibiotics — within 1 hour of recognition
4. IV crystalloid 30 mL/kg for hypotension or lactate ≥ 4 mmol/L
5. Vasopressors if refractory hypotension: norepinephrine is first-line (target MAP ≥ 65 mmHg)

Steps 2 and 3 are where people get burned. The exam loves to offer "start antibiotics immediately" as a tempting answer. It's almost right — but cultures come first. In real life, this delay is minutes, not hours. On the exam, sequence is everything.

Pearl worth remembering: The vasopressor ladder goes norepinephrine → vasopressin (0.03 units/min, added to reduce norepi dose) → epinephrine. Dopamine is NOT first-line — higher arrhythmia risk. And phenylephrine alone? Avoid it. Pure alpha-agonism drops cardiac output, which is the opposite of what your septic patient needs.

Antibiotic Selection for Sepsis

Here's my mental framework — it's faster than memorizing regimens:

• Unknown source, community-acquired: piperacillin-tazobactam + vancomycin (gram-negatives, anaerobes, and MRSA covered)
• Healthcare-associated or ICU: meropenem (or imipenem) + vancomycin ± antifungal (caspofungin) — you're worried about resistant organisms now
• Neutropenic fever: cefepime or pip-tazo monotherapy first; add vancomycin only if there's a catheter or skin source; add antifungal if fever persists beyond 4–7 days

The contrarian point here: many residents reflexively add vancomycin to every sepsis regimen. On the exam, that's wrong for neutropenic fever without a catheter source. Vancomycin isn't empiric first-line for neutropenic fever — cefepime alone is the answer unless the stem gives you a reason to add it.

HIV/AIDS

When to Start ART

Start antiretroviral therapy in all HIV-positive patients regardless of CD4 count. Full stop. This wasn't always consensus — a decade ago, we debated whether to wait until CD4 dropped below 500. The evidence is unambiguous now: earlier initiation reduces both transmission and progression to AIDS.

The one nuance the exam tests: in cryptococcal meningitis and TB meningitis, you delay ART briefly (2–4 weeks for crypto, 8 weeks for TB meningitis) to avoid immune reconstitution inflammatory syndrome (IRIS). That delay is the exception, not the rule.

CD4-Triggered Prophylaxis

This table is non-negotiable. You will see at least one question testing these thresholds:

CD4 Level	Opportunistic Infection Risk	Prophylaxis
< 500	Oral candidiasis, Kaposi sarcoma	No specific prophylaxis
< 200	PCP (Pneumocystis jirovecii pneumonia)	TMP-SMX DS once daily
< 100	Toxoplasma encephalitis	TMP-SMX (same dose — one pill covers both PCP and toxo)
< 50	MAC (Mycobacterium avium complex), CMV retinitis	Azithromycin 1200 mg/week (MAC); ophthalmology referral (CMV)

The beautiful thing about TMP-SMX: one daily double-strength tablet at CD4 < 200 simultaneously covers PCP and toxoplasmosis prophylaxis. The exam loves testing whether you know this is the same drug at the same dose doing double duty.

HIV-Associated OI Diagnosis

These four presentations are tested relentlessly. I tell my tutees: if you can pattern-match these in under 30 seconds, you'll save time for harder questions.

PCP pneumonia: Bilateral ground-glass infiltrates + hypoxia that seems disproportionate to how the CXR looks + CD4 < 200. LDH is elevated. BAL with silver stain shows Pneumocystis cysts. Treat with TMP-SMX. Here's the detail people miss: add prednisone if PaO2 < 70 or A-a gradient > 35. The steroids reduce mortality — it's one of the few situations where steroids in an active infection save lives.

Toxoplasma encephalitis: CD4 < 100 + multiple ring-enhancing lesions at the gray-white junction on MRI + positive Toxoplasma IgG. Don't biopsy first — treat empirically with pyrimethamine + sulfadiazine + folinic acid. Repeat MRI at 2 weeks. If the lesions improve, you've confirmed the diagnosis. If they don't, now you biopsy (and worry about CNS lymphoma).

Cryptococcal meningitis: CD4 < 100, subacute onset — and here's what catches people — about 40% of patients won't even have a fever. LP shows elevated opening pressure, India ink positivity, and cryptococcal antigen. Induction is amphotericin B + flucytosine for 2 weeks, then transition to fluconazole for consolidation and long-term maintenance.

CMV retinitis: CD4 < 50. Classic "pizza pie" fundoscopic appearance — hemorrhages and exudates scattered across the retina. Treat with IV ganciclovir or oral valganciclovir. The exam won't usually show you a fundus photo, but the description alone is enough.

Antibiotic Selection

Coverage Patterns You Actually Need

Forget trying to memorize every spectrum chart in First Aid. Focus on the gaps — what each drug doesn't cover — because that's how the exam writes distractors.

Antibiotic Class	Key Coverage	The Gap You Need to Know
Ceftriaxone	Strep pneumoniae, gram-negatives, N. gonorrhoeae	No MRSA, no Pseudomonas
Cefepime	Pseudomonas, gram-negatives	No MRSA; this is your febrile neutropenia drug
Piperacillin-tazobactam	Pseudomonas, gram-negatives, anaerobes	Broad but still no MRSA
Meropenem/imipenem	Widest gram-negative coverage (including ESBL), anaerobes	Reserve for resistant organisms; still no MRSA
Vancomycin	MRSA, Enterococcus, resistant gram-positives	Renal dosing required; monitor troughs
Daptomycin	MRSA (bacteremia, endocarditis, skin)	Cannot use for pneumonia — surfactant inactivates it
Linezolid	MRSA, VRE	MAO inhibitor — serotonin syndrome risk with SSRIs

The daptomycin-surfactant interaction is a favorite board question. Patient with MRSA bacteremia and pneumonia — daptomycin covers the bacteremia but you need vancomycin (or linezolid) for the lungs. If you pick daptomycin alone, you've missed the pneumonia coverage entirely.

Clostridioides difficile Treatment (Updated IDSA Guidelines)

This changed a few years ago and the old answer — metronidazole — will lose you points:

Severity	Treatment
Non-severe	Oral vancomycin 125 mg QID × 10 days OR fidaxomicin
Severe (WBC > 15K or Cr > 1.5)	Oral vancomycin 125 mg QID
Fulminant (hypotension, ileus, toxic megacolon)	Oral vancomycin 500 mg QID + IV metronidazole + surgical consult
Recurrent	Fidaxomicin OR bezlotoxumab OR FMT for multiple recurrences

Metronidazole is no longer first-line for any severity of CDI. The only place metronidazole still appears is as an adjunct in fulminant disease — given IV, because an ileus means oral drugs aren't reaching the colon. That's actually a surprisingly elegant pharmacology question when you think about it.

Vaccination

Live vs. Inactivated — The Real Decision Point

The question isn't usually "name a live vaccine." It's "can this specific patient receive this specific vaccine?" That requires knowing two lists cold.

Live vaccines (contraindicated in immunocompromised patients and pregnancy):

• MMR, varicella (Varivax), zoster live (Zostavax — no longer preferred anyway)
• Yellow fever, intranasal influenza (FluMist), oral typhoid (Ty21a)

Safe in immunocompromised patients:

• Recombinant zoster (Shingrix — preferred; 2 doses regardless of prior Zostavax)
• Inactivated influenza (injectable)
• Pneumococcal (PCV20, PPSV23)
• Hep A, Hep B, Tdap, HPV (safe but may have reduced immunogenicity)

Here's the insight that surprises most residents: Shingrix is NOT a live vaccine. It's recombinant. This means your immunocompromised patients — transplant recipients, HIV patients, patients on biologics — can and should receive it. The exam specifically tests whether you'll incorrectly withhold Shingrix from an immunosuppressed patient over age 50. Two doses, 2–6 months apart.

Frequently Asked Questions

Why is dopamine no longer first-line for septic shock?

Dopamine causes significantly more arrhythmias than norepinephrine without improving mortality. The 2010 De Backer trial settled this. Norepinephrine provides more reliable vasoconstriction with less cardiac irritability. The only remaining role for dopamine in sepsis guidelines is as an alternative in patients with low heart rate and low risk of tachyarrhythmia — a narrow scenario the exam rarely tests.

How do you distinguish CNS toxoplasmosis from primary CNS lymphoma on imaging?

Both present with ring-enhancing lesions in immunocompromised patients. Toxo lesions tend to be multiple and sit at the gray-white junction; CNS lymphoma is more often a single periventricular lesion. But you don't need to make the distinction upfront — treat empirically for toxo and reassess in 2 weeks. Lack of improvement prompts biopsy, which is how you diagnose lymphoma.

When should you delay ART in a newly diagnosed HIV patient?

Almost never. The two major exceptions are cryptococcal meningitis (delay 2–4 weeks) and tuberculous meningitis (delay ~8 weeks). The concern is IRIS — a paradoxical inflammatory flare when the recovering immune system attacks the existing infection. For most other OIs, including PCP, you start ART within 2 weeks of beginning OI treatment.

Can household contacts of immunocompromised patients receive live vaccines?

Yes, with one exception. MMR, varicella, and rotavirus vaccines can be given to household contacts safely. The one vaccine to avoid in close contacts is oral polio (OPV) — but OPV hasn't been used in the US since 2000, so this is mostly a historical footnote. FluMist (live attenuated intranasal influenza) should be avoided in contacts of severely immunocompromised patients, though injectable flu vaccine is fine.

Why is metronidazole no longer recommended for C. difficile?

Head-to-head trials showed vancomycin achieves higher cure rates with lower recurrence. Fidaxomicin performs even better for preventing recurrence. Metronidazole also has systemic absorption and neurotoxicity concerns with prolonged use. It retains a role only as IV adjunctive therapy in fulminant CDI, where ileus prevents oral medications from reaching the colon.

Practice Infectious Disease Questions

Ready to put this to work? Step3Sim offers free USMLE Step 3 practice questions for infectious disease covering sepsis management, HIV opportunistic infections, antibiotic stewardship, and more. The best way to lock in ID knowledge is active retrieval — and these cases are built to test exactly the decision points we covered here.